title: Acute suprachoroidal haemorrhage post-tenecteplase thrombolysis for myocardial infarction: management considerations.
abstract: We report a case of a 63-year-old man who received intravenous tenecteplase as thrombolytic therapy for an inferior ST elevation myocardial infarction. Three hours later he complained of blurred vision in the right eye and on examination had sustained a suprachoroidal haemorrhage. With conservative treatment the haemorrhage resolved, leading to a normalisation of visual acuity. To the authors' knowledge, no case reports exist of this rare complication following intravenous tenecteplase. We discuss implications for further thrombolysis and anticoagulation.
authors: Queen Alexandra Hospital, Ophthalmology, Southwick Hill Road, Cosham, Portsmouth, Hampshire PO6 3LY, UK. kha@doctors.org.uk
authors: Sameer
authors: S
authors: Trikha
authors: Alastair
authors: A
authors: Lockwood
authors: Narman
authors: N
authors: Puvanachandra
authors: James
authors: J
authors: Kirwan
mesh_terms: D000208:Acute Disease; D002832:Choroid Hemorrhage / Q000139:chemically induced*; D005343:Fibrinolytic Agents / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy*; D000077785:Tenecteplase; D015912:Thrombolytic Therapy / Q000379:methods*; D010959:Tissue Plasminogen Activator / Q000009:adverse effects*
chemical_list: D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator; D000077785:Tenecteplase